Biography
Jeeyoon Chung is an associate in Weil’s Technology & IP Transactions practice and is based in New York. Jeeyoon participates in advising Firm clients in a variety of matters relating to the licensing, acquisition, development, sale, use and commercial exploitation of intellectual property and technology. She also participates in advising clients regarding privacy and data security issues in the context of corporate transactions.
Jeeyoon has been part of teams advising on the technology and intellectual property aspects, as well as on the data privacy and cybersecurity aspects of the following matters:
- Goldman Sachs in its pending acquisition of NextCapital Group, Inc.
- Halozyme Therapeutics, Inc. in its $960 million acquisition of Antares Pharma, Inc.
- Warburg Pincus, as a co-investor with One Equity Partners, in the formation of Eco Material Technologies Inc. through a business combination with Green Cement Inc. and the $1 billion acquisition of Boral Resources LLC
Jeeyoon joined Weil as a summer associate in 2020.
Jeeyoon received her J.D. from Columbia Law School, where she was a Harlan Fiske Stone Scholar, was the president of the Asian Pacific American Law Students Association and served as the Development and Diversity Editor of the Columbia Law Review, and her B.A. from Johns Hopkins University. At Columbia, she was awarded the Carol B. Liebman Mediation Prize. She is fluent in Korean and French.
Awards and Recognition, Speaking Engagements, Guides and Resources, Latest Thinking, Firm News & Announcements
Firm News & Announcements
- Weil Advised Halozyme Therapeutics, Inc. in its $960M Acquisition of Antares Pharma, Inc. Deal Brief — May 24, 2022
- Weil Advised Halozyme Therapeutics, Inc. in its $960M Acquisition of Antares Pharma, Inc. Deal Brief — May 24, 2022